Bicara Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Bicara Therapeutics (Nasdaq: BCAX) said company leadership will attend multiple investor conferences in early March 2026, with live fireside chats and webcasts scheduled. Ryan Cohlhepp, Pharm.D., President and COO, will present at TD Cowen (Mar 2) and Barclays (Mar 10) and attend Jefferies Biotech on the Beach (Mar 10-11).

Live webcasts and archived replays will be available via the company’s Investor Relations Events and Presentations page.

News Market Reaction – BCAX

+5.94%

18 alerts

+5.94% News Effect

+4.9% Peak in 3 hr 1 min

+$52M Valuation Impact

$927M Market Cap

0.9x Rel. Volume

On the day this news was published, BCAX gained 5.94%, reflecting a notable positive market reaction. Argus tracked a peak move of +4.9% during that session. Our momentum scanner triggered 18 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $52M to the company's valuation, bringing the market cap to $927M at that time.

Data tracked by StockTitan Argus on the day of publication.

BOSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that company leadership will participate in multiple upcoming investor conferences.

Ryan Cohlhepp, Pharm.D., President and Chief Operating Officer at Bicara will take part in fireside chats at:

• TD Cowen 46^th Annual Health Care Conference
  
  

Date and Time: Monday, March 2, 1:10-1:40 p.m. ET in Boston

• Barclays 28^th Annual Global Healthcare Conference
  
  

Date and Time: Tuesday, March 10, 11:30-11:55 a.m. ET in Miami

Bicara management will also attend the 2026 Jefferies Biotech on the Beach Summit, taking place March 10-11 in Miami.

Live webcasts of the fireside chats will be accessible through the Investor Relations section of Bicara’s website under Events and Presentations. Replays of the webcasts will be archived and available following each event.

About Bicara Therapeutics
Bicara Therapeutics is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Bicara’s lead program, ficerafusp alfa, is a first-in-class bifunctional antibody designed to drive tumor penetration by breaking barriers in the tumor microenvironment that have challenged the treatment of multiple solid tumor cancers. Specifically, ficerafusp alfa combines two clinically validated targets: an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-β). Through this targeted mechanism, ficerafusp alfa reverses the fibrotic and immune-excluded tumor microenvironment driven by TGF-β signaling to enable tumor penetration that drives deep and durable responses. Ficerafusp alfa is being developed in head and neck squamous cell carcinoma, where there remains a significant unmet need, as well as other solid tumor types. For more information, please visit www.bicara.com or follow us on LinkedIn and X.

Contacts

Investors
Jenna Cohen
IR@bicara.com

Media
Amanda Lazaro
1AB
Amanda@1abmedia.com

FAQ

When will Bicara Therapeutics (BCAX) present at the TD Cowen 46th Annual Health Care Conference?

Bicara will present on Monday, March 2, 2026, from 1:10–1:40 p.m. ET. According to the company, Ryan Cohlhepp, Pharm.D., President and COO, will take part in a fireside chat and the session will be webcast live on the investor site.

What time is Bicara's (BCAX) fireside chat at the Barclays 28th Annual Global Healthcare Conference?

The fireside chat is scheduled for Tuesday, March 10, 2026, 11:30–11:55 a.m. ET. According to the company, the session will be webcast live and a replay will be archived on the Investor Relations Events and Presentations page after the event.

Will Bicara Therapeutics (BCAX) attend Jefferies Biotech on the Beach, and when is it?

Yes, Bicara management will attend Jefferies Biotech on the Beach, March 10–11, 2026. According to the company, leadership will be present for investor meetings and networking, with no specific presentation time listed in the announcement.

How can investors watch Bicara Therapeutics (BCAX) fireside chats if they cannot attend in person?

Investors can watch via live webcast through the company’s Investor Relations Events and Presentations page. According to the company, live streams will be available for each fireside chat and replays will be archived after the events for later viewing.

Who from Bicara Therapeutics (BCAX) will participate in the March 2026 investor conferences?

Ryan Cohlhepp, Pharm.D., President and COO, will take part in scheduled fireside chats and management will attend additional sessions. According to the company, leadership will appear at TD Cowen, Barclays, and Jefferies Biotech on the Beach in early March 2026.